The AREDS 2 Formula
Only PreserVation Eye Vitamin AREDS 2 Formula contains the exact levels of six nutrients recommended by the National Eye Institute to help reduce risk of progression in people with moderate to advanced age-related Macular Degeneration (AMD).
PreserVision Eye Vitamin AREDS 2 Formula builds on the original, clinically proven PreserVision AREDS formula, with lutein and zeaxanthin replacing beta-carotene based on the National Eye Institute's Age-Related Eye Disease Study 2 (AREDS 2).
- PreserVision is the #1 recommended brand by eye doctors for people with moderate-to-advanced age-related macular degeneration. Brought to you by Bausch + Lomb the leader in AREDS eye vitamins.
- The exact nutrient formula recommended by the National Eye Institute which includes lutein and zeaxanthin;Health Concerns: Eye Health
- The levels of antioxidants and zinc shown to be beneficial for people at risk of progression of AMD are not found in typical daily multivitamins.
#1 recommended brand by eye doctors for people with moderate-to-advanced AMD. Brought to you by Bausch + Lomb — the leader in eye vitamins. PreserVision AREDS2 Formula builds on the original, clinically proven PreserVision AREDS Formula, with lutein and zeaxanthin replacing beta-carotene based on the AREDS2 study. Complete AREDS2 Formula: This advanced PreserVision Formula contains the exact same levels of all six nutrients based on the latest clinical evidence from the AREDS2 study.3 Completed in 2013, the Age Related Eye Disease Study 2 (AREDS2) was a five-year study conducted by the National Eye Institute (NEI) of the National Institutes of Health. This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. 1 Wolters-Kluwer Pharma Solutions, B+L Brand Management Report, 5/13/112 March 2009 Retinal AMD Tracker, Decision Analysts, Inc. 3 The Age Related Eye Disease Study 2 (AREDS2) Research Group. Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration [published online]. JAMA. 2013;309(19):doi:10.1001/jama.2013.4997 4 NEI Press Release: NIH Study Provides Clarity on Supplements for Protection Against Blinding Eye Disease [published online], accessed May 17, 2013.